Cargando…
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
BACKGROUND: Trypanosoma cruzi parasite, the causative agent of Chagas disease, infects about six million individuals in more than 20 countries. Monitoring parasite persistence in infected individuals is of utmost importance to develop and evaluate treatments to control the disease. Routine screening...
Autores principales: | Zrein, Maan, Granjon, Elodie, Gueyffier, Lucie, Caillaudeau, Julie, Liehl, Peter, Pottel, Hans, Cardoso, Clareci Silva, Oliveira, Claudia Di Lorenzo, de Oliveira, Lea Campos, Lee, Tzong-Hae, Ferreira, Ariela Mota, Ribeiro, Antonio Luiz P., Busch, Michael P., Sabino, Ester Cerdeira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823467/ https://www.ncbi.nlm.nih.gov/pubmed/29425201 http://dx.doi.org/10.1371/journal.pntd.0006226 |
Ejemplares similares
-
Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies
por: Saba, Esber S., et al.
Publicado: (2013) -
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease
por: Granjon, Elodie, et al.
Publicado: (2016) -
Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation
por: Saba, Esber S., et al.
Publicado: (2015) -
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022) -
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections
por: Marqué, Lola, et al.
Publicado: (2021)